-
1
-
-
0036672879
-
2 consumption, NOS, and Na/H exchange in diabetic rat proximal tubules
-
2 consumption, NOS, and Na/H exchange in diabetic rat proximal tubules. Am J Physiol Renal Physiol 283: F286-F293, 2002. doi:10.1152/ajprenal.00330.2001.
-
(2002)
Am J Physiol Renal Physiol
, vol.283
, pp. F286-F293
-
-
Baines, A.1
Ho, P.2
-
2
-
-
84898854471
-
Effects of sodium-glucose co-transporter 2 inhibitors on blood pressure: A systematic review and meta-analysis
-
e9
-
Baker WL, Smyth LR, Riche DM, Bourret EM, Chamberlin KW, White WB. Effects of sodium-glucose co-transporter 2 inhibitors on blood pressure: a systematic review and meta-analysis. J Am Soc Hypertens 8: 262-275.e9, 2014. doi:10.1016/j.jash.2014.01.007.
-
(2014)
J am Soc Hypertens
, vol.8
, pp. 262-275
-
-
Baker, W.L.1
Smyth, L.R.2
Riche, D.M.3
Bourret, E.M.4
Chamberlin, K.W.5
White, W.B.6
-
3
-
-
0029640011
-
Hypoxia of the renal medulla-its implications for disease
-
Brezis M, Rosen S. Hypoxia of the renal medulla-its implications for disease. N Engl J Med 332: 647-655, 1995. doi:10.1056/NEJM199503093321006.
-
(1995)
N Engl J Med
, vol.332
, pp. 647-655
-
-
Brezis, M.1
Rosen, S.2
-
4
-
-
0023161134
-
The tubuloglomerular feedback mechanism: Functional and biochemical aspects
-
Briggs JP, Schnermann J. The tubuloglomerular feedback mechanism: functional and biochemical aspects. Annu Rev Physiol 49: 251-273, 1987. doi:10.1146/annurev.ph.49.030187.001343.
-
(1987)
Annu Rev Physiol
, vol.49
, pp. 251-273
-
-
Briggs, J.P.1
Schnermann, J.2
-
5
-
-
0029844420
-
Functional impairment of renal afferent arteriolar voltage-gated calcium channels in rats with diabetes mellitus
-
Carmines PK, Ohishi K, Ikenaga H. Functional impairment of renal afferent arteriolar voltage-gated calcium channels in rats with diabetes mellitus. J Clin Invest 98: 2564-2571, 1996. doi:10.1172/JCI119075.
-
(1996)
J Clin Invest
, vol.98
, pp. 2564-2571
-
-
Carmines, P.K.1
Ohishi, K.2
Ikenaga, H.3
-
6
-
-
84976496895
-
Modeling glucose metabolism in the kidney
-
Chen Y, Fry BC, Layton AT. Modeling glucose metabolism in the kidney. Bull Math Biol 78: 1318-1336, 2016. doi:10.1007/s11538-016-0188-7.
-
(2016)
Bull Math Biol
, vol.78
, pp. 1318-1336
-
-
Chen, Y.1
Fry, B.C.2
Layton, A.T.3
-
7
-
-
84893214045
-
Renal hemodynamic effect of sodium-glucose cotransporter 2 inhibition in patients with type 1 diabetes mellitus
-
Cherney DZI, Perkins BA, Soleymanlou N, Maione M, Lai V, Lee A, Fagan NM, Woerle HJ, Johansen OE, Broedl UC, von Eynatten M. Renal hemodynamic effect of sodium-glucose cotransporter 2 inhibition in patients with type 1 diabetes mellitus. Circulation 129: 587-597, 2014. doi:10.1161/CIRCULATIONAHA.113.005081.
-
(2014)
Circulation
, vol.129
, pp. 587-597
-
-
Cherney, D.1
Perkins, B.A.2
Soleymanlou, N.3
Maione, M.4
Lai, V.5
Lee, A.6
Fagan, N.M.7
Woerle, H.J.8
Johansen, O.E.9
Broedl, U.C.10
Von Eynatten, M.11
-
8
-
-
33644855811
-
Axial flow modulates proximal tubule NHE3 and H-ATPase activities by changing microvillus bending moments
-
Du Z, Yan Q, Duan Y, Weinbaum S, Weinstein AM, Wang T. Axial flow modulates proximal tubule NHE3 and H-ATPase activities by changing microvillus bending moments. Am J Physiol Renal Physiol 290: F289-F296, 2006. doi:10.1152/ajprenal.00255.2005.
-
(2006)
Am J Physiol Renal Physiol
, vol.290
, pp. F289-F296
-
-
Du, Z.1
Yan, Q.2
Duan, Y.3
Weinbaum, S.4
Weinstein, A.M.5
Wang, T.6
-
9
-
-
34948911363
-
End-stage renal disease in the United States: An update from the United States Renal Data System
-
Foley RN, Collins AJ. End-stage renal disease in the United States: an update from the United States Renal Data System. J Am Soc Nephrol 18: 2644-2648, 2007. doi:10.1681/ASN.2007020220.
-
(2007)
J am Soc Nephrol
, vol.18
, pp. 2644-2648
-
-
Foley, R.N.1
Collins, A.J.2
-
10
-
-
12844286168
-
Tubular dysfunction and hemodynamic alteration in normoalbuminuric type 2 diabetes
-
Futrakul N, Vongthavarawat V, Sirisalipotch S, Chairatanarat T, Futrakul P, Suwanwalaikorn S. Tubular dysfunction and hemodynamic alteration in normoalbuminuric type 2 diabetes. Clin Hemorheol Microcirc 32: 59-65, 2005.
-
(2005)
Clin Hemorheol Microcirc
, vol.32
, pp. 59-65
-
-
Futrakul, N.1
Vongthavarawat, V.2
Sirisalipotch, S.3
Chairatanarat, T.4
Futrakul, P.5
Suwanwalaikorn, S.6
-
11
-
-
0014277398
-
Functional correlates of compensatory renal hypertrophy
-
Hayslett JP, Kashgarian M, Epstein FH. Functional correlates of compensatory renal hypertrophy. J Clin Invest 47: 774-782, 1968. doi:10.1172/JCI105772.
-
(1968)
J Clin Invest
, vol.47
, pp. 774-782
-
-
Hayslett, J.P.1
Kashgarian, M.2
Epstein, F.H.3
-
12
-
-
85019556099
-
Response to Comment on Inzucchi et al. Pioglitazone prevents diabetes in patients with insulin resistance and cerebrovascular disease. Diabetes Care 2016; 39: 1684-1692
-
Inzucchi SE, Viscoli CM, Young LH, Furie KL, Gorman M, Lovejoy AM, Dagogo-Jack S, Ismail-Beigi F, Korytkowski MT, Pratley RE, Schwartz GG, Kernan WN; IRIS Trial Investigators. Response to Comment on Inzucchi et al. Pioglitazone prevents diabetes in patients with insulin resistance and cerebrovascular disease. Diabetes Care 2016; 39: 1684-1692. Diabetes Care 40: e47-e48, 2017. doi:10.2337/dci16-0048.
-
(2017)
Diabetes Care
, vol.40
, pp. e47-e48
-
-
Inzucchi, S.E.1
Viscoli, C.M.2
Young, L.H.3
Furie, K.L.4
Gorman, M.5
Lovejoy, A.M.6
Dagogo-Jack, S.7
Ismail-Beigi, F.8
Korytkowski, M.T.9
Pratley, R.E.10
Schwartz, G.G.11
Kernan, W.N.12
-
13
-
-
0016651612
-
Functional and hemodynamic adaptation to progressive renal ablation
-
Kaufman JM, Siegel NJ, Hayslett JP. Functional and hemodynamic adaptation to progressive renal ablation. Circ Res 36: 286-293, 1975. doi:10.1161/01.RES.36.2.286.
-
(1975)
Circ Res
, vol.36
, pp. 286-293
-
-
Kaufman, J.M.1
Siegel, N.J.2
Hayslett, J.P.3
-
14
-
-
77951959481
-
Changes in the sodium and potassium transporters in the course of chronic renal failure
-
Kim S, Heo NJ, Jung JY, Son M-J, Jang HR, Lee JW, Oh YK, Na KY, Joo KW, Han JS. Changes in the sodium and potassium transporters in the course of chronic renal failure. Nephron Physiol 115: p31-41, 2010. doi:10.1159/000314542.
-
(2010)
Nephron Physiol
, vol.115
, pp. p31-p41
-
-
Kim, S.1
Heo, N.J.2
Jung, J.Y.3
Son, M.-J.4
Jang, H.R.5
Lee, J.W.6
Oh, Y.K.7
Na, K.Y.8
Joo, K.W.9
Han, J.S.10
-
15
-
-
15144341987
-
Renal metabolism: Integrated responses
-
edited by Berliner RW. Oxford, UK: Oxford University Press
-
Klahr S, Hamm LL, Hammerman MR, Mandel LJ. Renal metabolism: integrated responses. In: Handbook of Physiology, edited by Berliner RW. Oxford, UK: Oxford University Press, 1989.
-
(1989)
Handbook of Physiology
-
-
Klahr, S.1
Hamm, L.L.2
Hammerman, M.R.3
Mandel, L.J.4
-
16
-
-
0028216159
-
Increased renal metabolism in diabetes. Mechanism and functional implications
-
Körner A, Eklöf A-C, Celsi G, Aperia A. Increased renal metabolism in diabetes. Mechanism and functional implications. Diabetes 43: 629-633, 1994. doi:10.2337/diab.43.5.629.
-
(1994)
Diabetes
, vol.43
, pp. 629-633
-
-
Körner, A.1
Eklöf, A.-C.2
Celsi, G.3
Aperia, A.4
-
17
-
-
79551573862
-
A mathematical model of the urine concentrating mechanism in the rat renal medulla. I. Formulation and base-case results
-
Layton AT. A mathematical model of the urine concentrating mechanism in the rat renal medulla. I. Formulation and base-case results. Am J Physiol Renal Physiol 300: F356-F371, 2011. doi:10.1152/ajprenal.00203.2010.
-
(2011)
Am J Physiol Renal Physiol
, vol.300
, pp. F356-F371
-
-
Layton, A.T.1
-
18
-
-
79551518894
-
Mathematical model of the urine concentrating mechanism in the rat renal medulla. II. Functional implications of three-dimensional architecture
-
Layton AT. A mathematical model of the urine concentrating mechanism in the rat renal medulla. II. Functional implications of three-dimensional architecture. Am J Physiol Renal Physiol 300: F372-F384, 2011. doi:10.1152/ajprenal.00204.2010.
-
(2011)
Am J Physiol Renal Physiol
, vol.300
, pp. F372-F384
-
-
Layton, A.1
-
20
-
-
85026783132
-
Adaptive changes in GFR, tubular morphology, and transport in subtotal nephrectomized kidneys: Modeling and analysis
-
Layton AT, Edwards A, Vallon V. Adaptive changes in GFR, tubular morphology, and transport in subtotal nephrectomized kidneys: modeling and analysis. Am J Physiol Renal Physiol 313: F199-F209, 2017. doi:10.1152/ajprenal.00018.2017.
-
(2017)
Am J Physiol Renal Physiol
, vol.313
, pp. F199-F209
-
-
Layton, A.T.1
Edwards, A.2
Vallon, V.3
-
22
-
-
85044431418
-
Cardiovascular benefits of SGLT 2 inhibition in diabetes and chronic kidney diseases
-
Layton AT, Vallon V. Cardiovascular benefits of SGLT 2 inhibition in diabetes and chronic kidney diseases. Acta Physiol 222: e13050, 2018. doi:10.1111/apha.13050.
-
(2018)
Acta Physiol
, vol.222
-
-
Layton, A.T.1
Vallon, V.2
-
23
-
-
84931095114
-
Modeling oxygen consumption in the proximal tubule: Effects of NHE and SGLT2 inhibition
-
Layton AT, Vallon V, Edwards A. Modeling oxygen consumption in the proximal tubule: effects of NHE and SGLT2 inhibition. Am J Physiol Renal Physiol 308: F1343-F1357, 2015. doi:10.1152/ajprenal.00007.2015.
-
(2015)
Am J Physiol Renal Physiol
, vol.308
, pp. F1343-F1357
-
-
Layton, A.T.1
Vallon, V.2
Edwards, A.3
-
24
-
-
85006324677
-
A computational model for simulating solute transport and oxygen consumption along the nephrons
-
Layton AT, Vallon V, Edwards A. A computational model for simulating solute transport and oxygen consumption along the nephrons. Am J Physiol Renal Physiol 311: F1378-F1390, 2016. doi:10.1152/ajprenal.00293.2016.
-
(2016)
Am J Physiol Renal Physiol
, vol.311
, pp. F1378-F1390
-
-
Layton, A.T.1
Vallon, V.2
Edwards, A.3
-
25
-
-
84984630329
-
Predicted consequences of diabetes and SGLT inhibition on transport and oxygen consumption along a rat nephron
-
Layton AT, Vallon V, Edwards A. Predicted consequences of diabetes and SGLT inhibition on transport and oxygen consumption along a rat nephron. Am J Physiol Renal Physiol 310: F1269-F1283, 2016. doi:10.1152/ajprenal.00543.2015.
-
(2016)
Am J Physiol Renal Physiol
, vol.310
, pp. F1269-F1283
-
-
Layton, A.T.1
Vallon, V.2
Edwards, A.3
-
26
-
-
85032165629
-
Sodium glucose cotransporter-2 inhibition in heart failure: Potential mechanisms, clinical applications, and summary of clinical trials
-
Lytvyn Y, Bjornstad P, Udell JA, Lovshin JA, Cherney DZI. Sodium glucose cotransporter-2 inhibition in heart failure: potential mechanisms, clinical applications, and summary of clinical trials. Circulation 136: 1643-1658, 2017. doi:10.1161/CIRCULATIONAHA.117.030012.
-
(2017)
Circulation
, vol.136
, pp. 1643-1658
-
-
Lytvyn, Y.1
Bjornstad, P.2
Udell, J.A.3
Lovshin, J.A.4
Cherney, D.Z.I.5
-
27
-
-
84900545175
-
Dominant factors that govern pressure natriuresis in diuresis and antidiuresis: A mathematical model
-
Moss R, Layton AT. Dominant factors that govern pressure natriuresis in diuresis and antidiuresis: a mathematical model. Am J Physiol Renal Physiol 306: F952-F969, 2014. doi:10.1152/ajprenal.00500.2013.
-
(2014)
Am J Physiol Renal Physiol
, vol.306
, pp. F952-F969
-
-
Moss, R.1
Layton, A.T.2
-
28
-
-
85023777061
-
Canagliflozin and cardiovascular and renal events in type 2 diabetes
-
Neal B, Perkovic V, Mahaffey KW, de Zeeuw D, Fulcher G, Erondu N, Shaw W, Law G, Desai M, Matthews DR. Canagliflozin and cardiovascular and renal events in type 2 diabetes. N Engl J Med 377: 644-657, 2017. doi:10.1056/NEJMoa1611925.
-
(2017)
N Engl J Med
, vol.377
, pp. 644-657
-
-
Neal, B.1
Perkovic, V.2
Mahaffey, K.W.3
De Zeeuw, D.4
Fulcher, G.5
Erondu, N.6
Shaw, W.7
Law, G.8
Desai, M.9
Matthews, D.R.10
-
29
-
-
14944349267
-
Cell survival in the hostile environment of the renal medulla
-
Neuhofer W, Beck FX. Cell survival in the hostile environment of the renal medulla. Annu Rev Physiol 67: 531-555, 2005. doi:10.1146/annurev.physiol.67.031103.154456.
-
(2005)
Annu Rev Physiol
, vol.67
, pp. 531-555
-
-
Neuhofer, W.1
Beck, F.X.2
-
30
-
-
0022458490
-
Effects of nephron loss on glomerular hemodynamics and morphology in diabetic rats
-
O’Donnell MP, Kasiske BL, Daniels FX, Keane WF. Effects of nephron loss on glomerular hemodynamics and morphology in diabetic rats. Diabetes 35: 1011-1015, 1986. doi:10.2337/diab.35.9.1011.
-
(1986)
Diabetes
, vol.35
, pp. 1011-1015
-
-
O’Donnell, M.P.1
Kasiske, B.L.2
Daniels, F.X.3
Keane, W.F.4
-
31
-
-
84901198078
-
Blood pressure effects of sodium-glucose co-transport 2 (SGLT2) inhibitors
-
Oliva RV, Bakris GL. Blood pressure effects of sodium-glucose co-transport 2 (SGLT2) inhibitors. J Am Soc Hypertens 8: 330-339, 2014. doi:10.1016/j.jash.2014.02.003.
-
(2014)
J am Soc Hypertens
, vol.8
, pp. 330-339
-
-
Oliva, R.V.1
Bakris, G.L.2
-
33
-
-
0042879795
-
Reactive oxygen species cause diabetes-induced decrease in renal oxygen tension
-
Palm F, Cederberg J, Hansell P, Liss P, Carlsson PO. Reactive oxygen species cause diabetes-induced decrease in renal oxygen tension. Diabetologia 46: 1153-1160, 2003. doi:10.1007/s00125-003-1155-z.
-
(2003)
Diabetologia
, vol.46
, pp. 1153-1160
-
-
Palm, F.1
Cederberg, J.2
Hansell, P.3
Liss, P.4
Carlsson, P.O.5
-
34
-
-
4143078293
-
Polyol-pathway-dependent disturbances in renal medullary metabolism in experimental insulin-deficient diabetes mellitus in rats
-
Palm F, Hansell P, Ronquist G, Waldenström A, Liss P, Carlsson PO. Polyol-pathway-dependent disturbances in renal medullary metabolism in experimental insulin-deficient diabetes mellitus in rats. Diabetologia 47: 1223-1231, 2004. doi:10.1007/s00125-004-1434-3.
-
(2004)
Diabetologia
, vol.47
, pp. 1223-1231
-
-
Palm, F.1
Hansell, P.2
Ronquist, G.3
Waldenström, A.4
Liss, P.5
Carlsson, P.O.6
-
35
-
-
85021694438
-
Differential effects of dapagliflozin on cardiovascular risk factors at varying degrees of renal function
-
Petrykiv S, Sjöström CD, Greasley PJ, Xu J, Persson F, Heerspink HJL. Differential effects of dapagliflozin on cardiovascular risk factors at varying degrees of renal function. Clin J Am Soc Nephrol 12: 751-759, 2017. doi:10.2215/CJN.10180916.
-
(2017)
Clin J am Soc Nephrol
, vol.12
, pp. 751-759
-
-
Petrykiv, S.1
Sjöström, C.D.2
Greasley, P.J.3
Xu, J.4
Persson, F.5
Heerspink, H.J.L.6
-
37
-
-
0030876055
-
Quantitative morphology of the rat kidney during diabetes mellitus and insulin treatment
-
Rasch R, Dørup J. Quantitative morphology of the rat kidney during diabetes mellitus and insulin treatment. Diabetologia 40: 802-809, 1997. doi:10.1007/s001250050752.
-
(1997)
Diabetologia
, vol.40
, pp. 802-809
-
-
Rasch, R.1
Dørup, J.2
-
38
-
-
0347419305
-
The molecular machinery of Keilin’s respiratory chain
-
Rich PR. The molecular machinery of Keilin’s respiratory chain. Biochem Soc Trans 31: 1095-1105, 2003. doi:10.1042/bst0311095.
-
(2003)
Biochem Soc Trans
, vol.31
, pp. 1095-1105
-
-
Rich, P.R.1
-
39
-
-
85019367291
-
Increased hematocrit during sodium-glucose cotransporter 2 inhibitor therapy indicates recovery of tubulointerstitial function in diabetic kidneys
-
Sano M, Takei M, Shiraishi Y, Suzuki Y. Increased hematocrit during sodium-glucose cotransporter 2 inhibitor therapy indicates recovery of tubulointerstitial function in diabetic kidneys. J Clin Med Res 8: 844-847, 2016. doi:10.14740/jocmr2760w.
-
(2016)
J Clin Med Res
, vol.8
, pp. 844-847
-
-
Sano, M.1
Takei, M.2
Shiraishi, Y.3
Suzuki, Y.4
-
40
-
-
84863393231
-
Hyperfiltration in type 1 diabetes: Does it exist and does it matter for nephropathy?
-
Thomas MC, Moran JL, Harjutsalo V, Thorn L, Wadén J, Saraheimo M, Tolonen N, Leiviskä J, Jula A, Forsblom C, Groop PH; FinnDiane Study Group. Hyperfiltration in type 1 diabetes: does it exist and does it matter for nephropathy? Diabetologia 55: 1505-1513, 2012. doi:10.1007/s00125-012-2485-5.
-
(2012)
Diabetologia
, vol.55
, pp. 1505-1513
-
-
Thomas, M.C.1
Moran, J.L.2
Harjutsalo, V.3
Thorn, L.4
Wadén, J.5
Saraheimo, M.6
Tolonen, N.7
Leiviskä, J.8
Jula, A.9
Forsblom, C.10
Groop, P.H.11
-
41
-
-
84255185190
-
Acute and chronic effects of SGLT2 blockade on glomerular and tubular function in the early diabetic rat
-
Thomson SC, Rieg T, Miracle C, Mansoury H, Whaley J, Vallon V, Singh P. Acute and chronic effects of SGLT2 blockade on glomerular and tubular function in the early diabetic rat. Am J Physiol Regul Integr Comp Physiol 302: R75-R83, 2012. doi:10.1152/ajpregu.00357.2011.
-
(2012)
Am J Physiol Regul Integr Comp Physiol
, vol.302
, pp. R75-R83
-
-
Thomson, S.C.1
Rieg, T.2
Miracle, C.3
Mansoury, H.4
Whaley, J.5
Vallon, V.6
Singh, P.7
-
42
-
-
0029586615
-
Homeostatic efficiency of tubuloglomerular feedback is reduced in established diabetes mellitus in rats
-
Vallon V, Blantz RC, Thomson S. Homeostatic efficiency of tubuloglomerular feedback is reduced in established diabetes mellitus in rats. Am J Physiol 269: F876-F883, 1995. doi:10.1152/ajprenal.1995.269.6.F876.
-
(1995)
Am J Physiol
, vol.269
, pp. F876-F883
-
-
Vallon, V.1
Blantz, R.C.2
Thomson, S.3
-
43
-
-
84892588641
-
SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice
-
Vallon V, Gerasimova M, Rose MA, Masuda T, Satriano J, Mayoux E, Koepsell H, Thomson SC, Rieg T. SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice. Am J Physiol Renal Physiol 306: F194-F204, 2014. doi:10.1152/ajprenal.00520.2013.
-
(2014)
Am J Physiol Renal Physiol
, vol.306
, pp. F194-F204
-
-
Vallon, V.1
Gerasimova, M.2
Rose, M.A.3
Masuda, T.4
Satriano, J.5
Mayoux, E.6
Koepsell, H.7
Thomson, S.C.8
Rieg, T.9
-
44
-
-
78651406659
-
SGLT2 mediates glucose reabsorption in the early proximal tubule
-
Vallon V, Platt KA, Cunard R, Schroth J, Whaley J, Thomson SC, Koepsell H, Rieg T. SGLT2 mediates glucose reabsorption in the early proximal tubule. J Am Soc Nephrol 22: 104-112, 2011. doi:10.1681/ASN.2010030246.
-
(2011)
J am Soc Nephrol
, vol.22
, pp. 104-112
-
-
Vallon, V.1
Platt, K.A.2
Cunard, R.3
Schroth, J.4
Whaley, J.5
Thomson, S.C.6
Koepsell, H.7
Rieg, T.8
-
45
-
-
0032707179
-
Glomerular hyperfiltration in experimental diabetes mellitus: Potential role of tubular reabsorption
-
Vallon V, Richter K, Blantz RC, Thomson S, Osswald H. Glomerular hyperfiltration in experimental diabetes mellitus: potential role of tubular reabsorption. J Am Soc Nephrol 10: 2569-2576, 1999.
-
(1999)
J am Soc Nephrol
, vol.10
, pp. 2569-2576
-
-
Vallon, V.1
Richter, K.2
Blantz, R.C.3
Thomson, S.4
Osswald, H.5
-
46
-
-
84872400230
-
Knockout of Na-glucose transporter SGLT2 attenuates hyperglycemia and glomerular hyperfiltration but not kidney growth or injury in diabetes mellitus
-
Vallon V, Rose M, Gerasimova M, Satriano J, Platt KA, Koepsell H, Cunard R, Sharma K, Thomson SC, Rieg T. Knockout of Na-glucose transporter SGLT2 attenuates hyperglycemia and glomerular hyperfiltration but not kidney growth or injury in diabetes mellitus. Am J Physiol Renal Physiol 304: F156-F167, 2013. doi:10.1152/ajprenal.00409.2012.
-
(2013)
Am J Physiol Renal Physiol
, vol.304
, pp. F156-F167
-
-
Vallon, V.1
Rose, M.2
Gerasimova, M.3
Satriano, J.4
Platt, K.A.5
Koepsell, H.6
Cunard, R.7
Sharma, K.8
Thomson, S.C.9
Rieg, T.10
-
47
-
-
84979895487
-
Empagliflozin and progression of kidney disease in type 2 diabetes
-
Wanner C, Inzucchi SE, Lachin JM, Fitchett D, von Eynatten M, Mattheus M, Johansen OE, Woerle HJ, Broedl UC, Zinman B; EMPA-REG OUTCOME Investigators. Empagliflozin and progression of kidney disease in type 2 diabetes. N Engl J Med 375: 323-334, 2016. doi:10.1056/NEJMoa1515920.
-
(2016)
N Engl J Med
, vol.375
, pp. 323-334
-
-
Wanner, C.1
Inzucchi, S.E.2
Lachin, J.M.3
Fitchett, D.4
Von Eynatten, M.5
Mattheus, M.6
Johansen, O.E.7
Woerle, H.J.8
Broedl, U.C.9
Zinman, B.10
-
48
-
-
85042792101
-
Empagliflozin and clinical outcomes in patients with type 2 diabetes, established cardiovascular disease, and chronic kidney disease
-
Wanner C, Lachin JM, Inzucchi SE, Fitchett D, Mattheus M, George JT, Woerle HJ, Broedl UC, von Eynatten M, Zinman B. Empagliflozin and clinical outcomes in patients with type 2 diabetes, established cardiovascular disease, and chronic kidney disease. Circulation 137: 119-129, 2018. doi:10.1161/CIRCULATIONAHA.117.028268.
-
(2018)
Circulation
, vol.137
, pp. 119-129
-
-
Wanner, C.1
Lachin, J.M.2
Inzucchi, S.E.3
Fitchett, D.4
Mattheus, M.5
George, J.T.6
Woerle, H.J.7
Broedl, U.C.8
Von Eynatten, M.9
Zinman, B.10
-
49
-
-
34147149220
-
Flow-dependent transport in a mathematical model of rat proximal tubule
-
Weinstein AM, Weinbaum S, Duan Y, Du Z, Yan Q, Wang T. Flow-dependent transport in a mathematical model of rat proximal tubule. Am J Physiol Renal Physiol 292: F1164-F1181, 2007. doi:10.1152/ajprenal.00392.2006.
-
(2007)
Am J Physiol Renal Physiol
, vol.292
, pp. F1164-F1181
-
-
Weinstein, A.M.1
Weinbaum, S.2
Duan, Y.3
Du, Z.4
Yan, Q.5
Wang, T.6
-
50
-
-
84944800184
-
Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes
-
Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, Mattheus M, Devins T, Johansen OE, Woerle HJ, Broedl UC, Inzucchi SE; EMPA-REG OUTCOME Investigators. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med 373: 2117-2128, 2015. doi:10.1056/NEJMoa1504720.
-
(2015)
N Engl J Med
, vol.373
, pp. 2117-2128
-
-
Zinman, B.1
Wanner, C.2
Lachin, J.M.3
Fitchett, D.4
Bluhmki, E.5
Hantel, S.6
Mattheus, M.7
Devins, T.8
Johansen, O.E.9
Woerle, H.J.10
Broedl, U.C.11
Inzucchi, S.E.12
|